no code implementations • 7 Sep 2021 • Xiong Liu, Cheng Shi, Uday Deore, Yingbo Wang, Myah Tran, Iya Khalil, Murthy Devarakonda
FDA has been promoting enrollment practices that could enhance the diversity of clinical trial populations, through broadening eligibility criteria.
